Pharmacokinetics and bioequivalence assessment of optimized directly compressible Aceclofenac (100 mg) tablet formulation in healthy human subjects

The aim of the study was to determine the various pharmacokinetic parameters of the newly developed cost-effective aceclofenac 100 mg tablet formulation (F-15) and to establish the bioequivalence against the marketed brand (ACEMED). Both products (test and reference) were given to 12 healthy non-smo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bushra, Rabia, Shoaib, Muhammad Harris, Ali, Huma, Ghayas, Sana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478617/
https://www.ncbi.nlm.nih.gov/pubmed/32898192
http://dx.doi.org/10.1371/journal.pone.0238951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478617/
https://www.ncbi.nlm.nih.gov/pubmed/32898192
http://dx.doi.org/10.1371/journal.pone.0238951

Ejemplares similares